DrugLib.com — Drug Information Portal

Rx drug information, pharmaceutical research, clinical trials, news, and more

Lunesta (Eszopiclone) - Published Studies

 
 



Lunesta Related Published Studies

Well-designed clinical trials related to Lunesta (Eszopiclone)

A randomized, double-blind, placebo-controlled trial of eszopiclone for the treatment of insomnia in patients with chronic low back pain. [2014]

Eszopiclone for insomnia associated with attention-deficit/hyperactivity disorder. [2014]

Effect of eszopiclone on sleep, fatigue, and pain in patients with mucositis associated with hematologic malignancies. [2011.12]

Eszopiclone for the treatment of posttraumatic stress disorder and associated insomnia: a randomized, double-blind, placebo-controlled trial. [2011.07]

A post hoc analysis of the effect of nightly administration of eszopiclone and a selective serotonin reuptake inhibitor in patients with insomnia and anxious depression. [2011.04]

Treatment of insomnia in Parkinson's disease: a controlled trial of eszopiclone and placebo. [2010.08.15]

Economic outcomes of eszopiclone treatment in insomnia and comorbid major depressive disorder. [2010.03]

A 12-week, randomized, double-blind, placebo-controlled study evaluating the effect of eszopiclone 2 mg on sleep/wake function in older adults with primary and comorbid insomnia. [2010.02.01]

Eszopiclone improves insomnia and depressive and anxious symptoms in perimenopausal and postmenopausal women with hot flashes: a randomized, double-blinded, placebo-controlled crossover trial. [2010.02]

A 12-week, randomized, double-blind, placebo-controlled study evaluating the effect of eszopiclone 2 mg on sleep/wake function in older adults with primary and comorbid insomnia. [2010.02]

Treatment of insomnia in Parkinson's disease: a controlled trial of eszopiclone and placebo. [2010]

Economic outcomes of eszopiclone treatment in insomnia and comorbid major depressive disorder. [2010]

A 12-week, randomized, double-blind, placebo-controlled study evaluating the effect of eszopiclone 2 mg on sleep/wake function in older adults with primary and comorbid insomnia. [2010]

Eszopiclone improves insomnia and depressive and anxious symptoms in perimenopausal and postmenopausal women with hot flashes: a randomized, double-blinded, placebo-controlled crossover trial. [2010]

A double-blind study of the influences of eszopiclone on dysgeusia and taste function. [2009.12]

Effects of a short course of eszopiclone on continuous positive airway pressure adherence: a randomized trial. [2009.11.17]

Eszopiclone improves overnight polysomnography and continuous positive airway pressure titration: a prospective, randomized, placebo-controlled trial. [2008.09.01]

Next-day cognition, psychomotor function, and driving-related skills following nighttime administration of eszopiclone. [2008.07]

A polysomnographic placebo-controlled evaluation of the efficacy and safety of eszopiclone relative to placebo and zolpidem in the treatment of primary insomnia. [2008.06.15]

Eszopiclone coadministered with escitalopram in patients with insomnia and comorbid generalized anxiety disorder. [2008.05]

Nightly treatment of primary insomnia with eszopiclone for six months: effect on sleep, quality of life, and work limitations. [2007.08.01]

Evaluation of eszopiclone discontinuation after cotherapy with fluoxetine for insomnia with coexisting depression. [2007.02.15]

Eszopiclone in patients with insomnia during perimenopause and early postmenopause: a randomized controlled trial. [2006.12]

A polysomnography study of eszopiclone in elderly patients with insomnia. [2006.09]

Eszopiclone co-administered with fluoxetine in patients with insomnia coexisting with major depressive disorder. [2006.06.01]

An evaluation of the efficacy and safety of eszopiclone over 12 months in patients with chronic primary insomnia. [2005.11]

A 2-week efficacy and safety study of eszopiclone in elderly patients with primary insomnia. [2005.06.01]

An assessment of the efficacy and safety of eszopiclone in the treatment of transient insomnia in healthy adults. [2005.01]

Efficacy and safety of eszopiclone across 6-weeks of treatment for primary insomnia. [2004.12]

Sustained efficacy of eszopiclone over 6 months of nightly treatment: results of a randomized, double-blind, placebo-controlled study in adults with chronic insomnia. [2003.11.01]

Well-designed clinical trials possibly related to Lunesta (Eszopiclone)

Objective vs. subjective measurements of sleep in depressed insomniacs: first night effect or reverse first night effect? [2012]

The Movement Disorder Society Evidence-Based Medicine Review Update: Treatments for the non-motor symptoms of Parkinson's disease. [2011.10]

Psychomotor performance after intake of zopiclone compared with intake of ethanol: a randomized, controlled, double-blinded trial. [2011.08]

Dissection of the factors driving the placebo effect in hypnotic treatment of depressed insomniacs. [2011.06]

Mindfulness-based stress reduction versus pharmacotherapy for chronic primary insomnia: a randomized controlled clinical trial. [2011.03]

Dissection of the factors driving the placebo effect in hypnotic treatment of depressed insomniacs. [2011]

Treatment of insomnia in depressed insomniacs: effects on health-related quality of life, objective and self-reported sleep, and depression. [2010.08.15]

Treatment of insomnia in depressed insomniacs: effects on health-related quality of life, objective and self-reported sleep, and depression. [2010]

Insomnia severity is an indicator of suicidal ideation during a depression clinical trial. [2010]

Sedative use during continuous positive airway pressure titration improves subsequent compliance: a randomized, double-blind, placebo-controlled trial. [2009.11]

Interpreting score differences in the Insomnia Severity Index: using health-related outcomes to define the minimally important difference. [2009.10]

Sedative Use During CPAP Titration Improves Subsequent Compliance. A Randomized, Double-Blinded, Placebo-Controlled Trial. [2009.06.30]

Does effective management of sleep disorders reduce depressive symptoms and the risk of depression? [2009]

The CYP2C8 inhibitor gemfibrozil does not increase the plasma concentrations of zopiclone. [2006.08]

Cognitive behavioral therapy vs zopiclone for treatment of chronic primary insomnia in older adults: a randomized controlled trial. [2006.06.28]

Sequential combinations of drug and cognitive behavioral therapy for chronic insomnia: an exploratory study. [2005.12]

Next-day residual effects of hypnotics in DSM-IV primary insomnia: a driving simulator study with simultaneous electroencephalogram monitoring. [2005.10]

Sleep-inducing pharmaceuticals: a comparison of melatonin, zaleplon, zopiclone, and temazepam. [2004.06]

Comparison of lorazepam and zopiclone for insomnia in patients with stroke and brain injury: a randomized, crossover, double-blinded trial. [2004.06]

Impact of melatonin, zaleplon, zopiclone, and temazepam on psychomotor performance. [2003.12]

Effects on postural oscillation and memory functions of a single dose of zolpidem 5 mg, zopiclone 3.75 mg and lormetazepam 1 mg in elderly healthy subjects. A randomized, cross-over, double-blind study versus placebo. [2003.07]

[Study of the real situation of improvement by Zopiclone in treatment of insomnia among persons working during night shifts] [2002.11]

[Comparison of zopiclone and midazolam premedication for preoperative anxiolysis] [2002.10]

Melatonin and zopiclone: the relationship between sleep propensity and body temperature. [2002.05.01]

Differential residual effects of zaleplon and zopiclone on actual driving: a comparison with a low dose of alcohol. [2002.03.15]

Actigraphic assessment of the preoperative hypnotic effects of brotizolam and zopiclone. [2002]

Efficacy and safety of tianeptine in major depression: evidence from a 3-month controlled clinical trial versus paroxetine. [2002]

Melatonin and zopiclone as pharmacologic aids to facilitate crew rest. [2001.11]

[Homeopathic specialties as substitutes for benzodiazepines: double-blind vs. placebo study] [2001.07]

A double-blind, randomized and placebo-controlled study on the polysomnographic withdrawal effects of zopiclone, zolpidem and triazolam in healthy subjects. [2001.06]

A double-blind comparative study of zolpidem versus zopiclone in the treatment of chronic primary insomnia. [2001.05]

The effect of single oral doses of zopiclone on nocturnal melatonin secretion in healthy male volunteers. [2001.05]

The effects of zolpidem and zopiclone on daytime sleepiness and psychomotor performance. [2000.08]

Effects of zolpidem and zopiclone on cognitive and attentional function in young healthy volunteers: an event-related potential study. [2000.02]

Effect of zopiclone and temazepam on sleep EEG parameters, psychomotor and memory functions in healthy elderly volunteers. [2000.01]

Residual effects of hypnotics on disengagement of spatial attention. [2000]

Independent sleep EEG slow-wave and spindle band dynamics associated with 4 weeks of continuous application of short-half-life hypnotics in healthy subjects. [1999.11]

The effects of substituting zopiclone in withdrawal from chronic use of benzodiazepine hypnotics. [1998.12]

Rebound insomnia after hypnotic withdrawal in insomniac outpatients. [1998]

Zopiclone as night medication in rheumatoid arthritis. [1998]

Effect of zopiclone on sleep, night-time ventilation, and daytime vigilance in upper airway resistance syndrome. [1997.11]

Multidrug comparison (lorazepam, triazolam, zolpidem, and zopiclone) in situational insomnia: polysomnographic analysis by means of the cyclic alternating pattern. [1997.06]

Concentrations and effects of zopiclone are greatly reduced by rifampicin. [1997.05]

Is hypnotic withdrawal facilitated by the transitory use of a substitute drug? [1997.01]

A comparison of zopiclone and propiomazine as hypnotics in outpatients: a multicentre, double-blind, randomized, parallel-group comparison of zopiclone and propiomazine in insomniacs. [1997]

Relationship between the effects of a hypnotic drug, zopiclone, on polysomnography and on daytime EEGs. [1997]

Zopiclone pharmacodynamics: by monitoring event-related potentials and psychometric scores. [1996.08]

Effect of itraconazole on the pharmacokinetics and pharmacodynamics of zopiclone. [1996]

[Study of zopiclone with quantitative EEG analysis and topography] [1995.08]

Double-blind comparison of zopiclone and flunitrazepam in elderly insomniacs with special focus on residual effects. [1995]

ECG activity in the sleep of insomniac patients under the influence of lormetazepam and zopiclone. [1995]

Zopiclone as a preoperative night hypnotic: a double-blind comparison with temazepam and placebo. [1994.04]

Zopiclone improves sleep quality and daytime well-being in insomniac patients: comparison with triazolam, flunitrazepam and placebo. [1994.01]

Effects of zopiclone, triazolam, and nitrazepam on standing steadiness. [1994]

Suriclone enhances the actions of chlorpromazine on human psychomotor performance but not on memory or plasma prolactin in healthy subjects. [1994]

Effects of zopiclone on slow wave sleep and spontaneous K-complexes for normal healthy young adults. [1993.12]

Effect of zopiclone on sleep quality, morning stiffness, widespread tenderness and pain and general discomfort in primary fibromyalgia patients. A double-blind randomized trial. [1993.06]

[Periodic discharges of sleep spindles with placebo and zopiclone] [1992.12]

A comparison of efficacy and tolerance of the short acting sedatives midazolam and zopiclone. [1992.10.28]

Interactions and comparative effects of zopiclone, diazepam and lorazepam on psychomotor performance and on elimination pharmacokinetics in healthy volunteers. [1992.02]

Pattern recognition by matched filtering: an analysis of sleep spindle and K-complex density under the influence of lormetazepam and zopiclone. [1992]

Zopiclone in the treatment of sleep abnormalities in fibromyalgia. [1991]

Effects of hypnotics on sleep and psychomotor performance. A double-blind randomised study of lormetazepam, midazolam and zopiclone. [1990.12]

Zopiclone versus flurazepam in insomnia: prolonged administration and withdrawal. [1990.10]

Actions of zopiclone and carbamazepine, alone and in combination, on human skilled performance in laboratory and clinical tests. [1990.09]

Zopiclone and triazolam in insomnia associated with generalized anxiety disorder: a placebo-controlled evaluation of efficacy and daytime anxiety. [1990.07]

A double-blind placebo-controlled trial of zopiclone 7.5 mg and temazepam 20 mg in insomnia. [1990.07]

The effect of zopiclone 7.5 mg on the sleep, mood and performance of shift workers. [1990.04]

A comparison of the efficacy, tolerance and residual effects of zopiclone, flurazepam and placebo in insomniac outpatients. [1990.04]

Zopiclone versus triazolam in insomniac geriatric patients: a specific increase in delta sleep with zopiclone. [1990.04]

Efficacy and safety of zopiclone and triazolam in the treatment of geriatric insomniacs. [1990.04]

-- advertisement -- The American Red Cross
 
Home | About Us | Contact Us | Site usage policy | Privacy policy

All Rights reserved - Copyright DrugLib.com, 2006-2017